XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Accounting Policies and Concentrations of Risk (Tables)
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Summary of Revenues
The Company recorded the following revenues for the three months ended March 31, 2024 and 2023 (in thousands):
Three Months Ended March 31,
20242023
Product sales, net$89,272 $68,166 
Collaborative and other revenues3,489 612 
Total revenues$92,761 $68,778 
The Company recorded the following revenues for the three months ended March 31, 2024 and 2023 (in thousands):
Three Months Ended March 31,
20242023
ORLADEYO:
U.S.$79,966 $60,849 
Outside of U.S.8,901 7,565 
Total ORLADEYO88,867 68,414 
Other revenues3,894 364 
Total revenues$92,761 $68,778 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The Company excluded the following potential common shares, presented based on amounts outstanding as of March 31, 2024 and March 31, 2023, from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:
March 31,
20242023
Outstanding stock options39,580 35,858 
Unvested restricted stock unit awards6,124 4,654 
Warrants to purchase common stock— 15,023 
Total45,704 55,535